Two-and-a-half-years in

Two-and-a-half-years into Diverge, and what a journey it has been.

2019 was all about the digital strategies of big pharma towards digital biomarkers, patient companions, platform and ecosystem thinking.

2020 was all about … COVID-19 obviously, but it also brought 2 most inspiring projects, enabling me to combine a historical passion for life sciences and medical biotech with a more recent interest in digital health.

Well into 2021, both projects have been extended:

  • into a structural lead in Strategy, Business and Client development for my favourite preclinical CRO focused on in vivo pharmacology of novel Alzheimer, Parkinson and Huntington therapies, and
  • into a Project and Partnership management role for the design-and-build of a data-platform enabled experimental hub that lowers the threshold to validate innovation ideas build on the better unlocking, exchange & sharing of health data.

Two worlds of real opportunity for multi-stakeholder value creation in healthcare, my number one ambition. Truly humbled and thankful for that.

What’s in a name

The name Diverge is a playful wink towards my private journey into the “new normal” of work. Contemporary employment is increasingly diverging from the classical payroll model towards the building or enriching of teams with independent professionals. It took some time, honest feedback and the unrelenting support and belief of many people to discover this emerging model is a perfect fit for me. Enabling me to work with people whom I trust, that inspire and energise me. Allowing me to truly create value, make meaning and have impact. Get ready for the convergence of the divergent ones, as they have infinity as their limit!